A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Investigational Drug Gaining Traction Via Social Media
The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are urged to contact these accounts directly for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” images, injection guides and claims of rapid UK delivery. Sellers market the substance there before redirecting customers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Professionals Voice Concerns
Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unapproved medication in the United Kingdom is worrisome and could lead to individuals administering products of uncertain source.
Several professionals stated the popularity for the experimental drug could be connected to the rising cost of approved weight loss products such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or imprisonment.
Service Response and Material Elimination
According to TikTok, the platform has taken down problematic material and banned related keywords and search suggestions. The company stated it was dedicated to keeping the service safe and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Investigations also found communities with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, populated with images of slimming results, glowing reviews and detailed guides for mixing or injecting at home.
After minutes of entering one group, a vendor posted WhatsApp details, where the majority of transactions take place. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.
Product Details and Costs
Inside these groups, messages display dark colored packages with postal service labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at residence with sterile water, or pre-filled pens usually sold at £160 for 20mg. When asked how long a injector should last, sellers give contradictory responses ranging from a several days to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for the messaging service stated it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is sound, these online products may not contain what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.
Her team has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental substance not yet approved … may subject patients to potentially significant health risks”.
